Lincoln Pharmaceuticals Share Price Target For Tomorrow, Next Week & Next Month
Lincoln Pharmaceuticals Limited | |||
 | Price: ₹549.95 (-0.12%) | ||
| 52 Week Low: ₹499.00 52 Week High: ₹979.50 | |||
| Market Capital: 1,237.63 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Lincoln Pharmaceuticals Stock Comparison: Lincoln Pharmaceuticals vs Bajaj HealthCare | Lincoln Pharmaceuticals vs Bliss GVS Pharma | Lincoln Pharmaceuticals vs Jagsonpal Pharmaceuticals | Lincoln Pharmaceuticals vs Syncom Formulations | Lincoln Pharmaceuticals vs Windlas Biotech | Lincoln Pharmaceuticals vs Zota Health Care | |||
Show Table of Contents
Lincoln Pharmaceuticals Recent Performance
Over the past 423 trading days, the value of Lincoln Pharmaceuticals's stock has lost ₹3.15 (-0.57%). On 07 Nov 2023, one share was worth ₹553.10 and by 24 Jul 2025, the value dropped to ₹549.95. During this period it created a highest high of ₹979.50 and lowest low of ₹499.00.
Lincoln Pharmaceuticals Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 582.4 (+5.9%) | Price Action: 17 Apr 2025 High |
| Tomorrow Target 2 | 576 (+4.73%) | Price Action: 06 Mar 2025 High |
| Tomorrow Target 1 | 569.6 (+3.57%) | Price Action: 24 Mar 2025 High |
| Current Price | 549.95 | Lincoln Pharmaceuticals's share price as of 24 Jul 2025 |
| Stop Loss 1 | 530.95 (-3.46%) | Price Action: 08 Apr 2025 Low |
| Stop Loss 2 | 524 (-4.72%) | Price Action: 13 Mar 2025 Low |
| Stop Loss 3 | 517 (-6%) | Price Action: 17 Mar 2025 Low |
Summary
24 Jul 2025: Lincoln Pharmaceuticals finished the day at ₹549.95, losing ₹-0.65 (-0.12%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -5.99% to 5.90% with:
- Target prices: ₹569.6 to ₹582.4
- Support levels: ₹530.95 to ₹517
- Recent high: ₹557.00
- Recent low: ₹549.00
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Lincoln Pharmaceuticals Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 565.95 (+2.9%) | Price Action: 28 Mar 2025 High |
| Next Week Target 2 | 560 (+1.82%) | Price Action: 20 Mar 2025 High |
| Next Week Target 1 | 554.45 (+0.81%) | Price Action: 03 Jun 2025 High |
| Current Price | 549.95 | Lincoln Pharmaceuticals's share price as of 24 Jul 2025 |
| Stop Loss 1 | 548.05 (-0.35%) | Price Action: 06 May 2025 Low |
| Stop Loss 2 | 542.2 (-1.41%) | Price Action: 28 May 2025 Low |
| Stop Loss 3 | 536.67 (-2.42%) | Fibonacci Retracement Level 61.80% |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -2.41% to 2.91% with:
- Upper targets: ₹554.45 to ₹565.95
- Support levels: ₹548.05 to ₹536.67
Lincoln Pharmaceuticals Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 587 (+6.73%) | Price Action: 22 Apr 2025 High |
| Next Month Target 2 | 580.63 (+5.57%) | Fibonacci Extension Level 23.60% |
| Next Month Target 1 | 574.8 (+4.51%) | Price Action: 12 May 2025 High |
| Current Price | 549.95 | Lincoln Pharmaceuticals's share price as of 24 Jul 2025 |
| Stop Loss 1 | 542.8 (-1.31%) | Price Action: 19 Mar 2025 Low |
| Stop Loss 2 | 535.66 (-2.6%) | Fibonacci Retracement Level 71.80% |
| Stop Loss 3 | 530.15 (-3.61%) | Price Action: 04 Mar 2025 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -3.60% to 6.74% with:
- Target range: ₹574.8 to ₹587
- Support levels: ₹542.8 to ₹530.15
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
